Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Hanlon

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Schizophrenia Bulletin|January 1, 1984
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndromeD W Heinrichs, T E Hanlon, W T Carpenter
Maryland Medical Journal (Baltimore, Md. : 1985)|January 1, 1994
The nature and status of drug abuse treatmentD N Nurco, T W Kinlock, T E Hanlon
The American Journal of Psychiatry|April 1, 1981
Methodologic standards for treatment outcome research in schizophreniaW T Carpenter, D W Heinrichs, T E Hanlon
International Pharmacopsychiatry|January 1, 1975
Effects of control techniques on therapeutic outcome in a controlled clinical trialT E Hanlon, R J Blatchley, A A Kurland
The International Journal of the Addictions|August 1, 1990
Aftercare/relapse prevention and the self-help movementD N Nurco, P E Stephenson, T E Hanlon
Diseases of the Nervous System|March 1, 1970
Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramineT E Hanlon, K Y Ota, A A Kurland
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1972
Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugsI Turek, A A Kurland, T E Hanlon, et al.
The Journal of Nervous and Mental Disease|May 1, 1974
A psychopharmacological study of catecholamines in affective disordersF S Messiha, C Savage, I Turek, et al.
Journal of Clinical Pharmacology|November 1, 1983
The prolactin response to flutroline hydrochloride in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
International Pharmacopsychiatry|January 1, 1975
A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addictT E Hanlon, O L McCabe, C Savage, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Schizophrenia Bulletin|January 1, 1984
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndromeD W Heinrichs, T E Hanlon, W T Carpenter
Maryland Medical Journal (Baltimore, Md. : 1985)|January 1, 1994
The nature and status of drug abuse treatmentD N Nurco, T W Kinlock, T E Hanlon
The American Journal of Psychiatry|April 1, 1981
Methodologic standards for treatment outcome research in schizophreniaW T Carpenter, D W Heinrichs, T E Hanlon
International Pharmacopsychiatry|January 1, 1975
Effects of control techniques on therapeutic outcome in a controlled clinical trialT E Hanlon, R J Blatchley, A A Kurland
The International Journal of the Addictions|August 1, 1990
Aftercare/relapse prevention and the self-help movementD N Nurco, P E Stephenson, T E Hanlon
Diseases of the Nervous System|March 1, 1970
Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramineT E Hanlon, K Y Ota, A A Kurland
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1972
Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugsI Turek, A A Kurland, T E Hanlon, et al.
The Journal of Nervous and Mental Disease|May 1, 1974
A psychopharmacological study of catecholamines in affective disordersF S Messiha, C Savage, I Turek, et al.
Journal of Clinical Pharmacology|November 1, 1983
The prolactin response to flutroline hydrochloride in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.
International Pharmacopsychiatry|January 1, 1975
A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addictT E Hanlon, O L McCabe, C Savage, et al.
Pageof 5